It's not uncommon for startups, especially in rapidly evolving ecosystems like India's, to delay filing their financials for various reasons. As many
Pharmeasy was looking to raise nearly $200 million in primary capital from investors based in the US and Southeast Asia.
A Velumani feels an individual has to mortgage mind, heart and freedom in order to buy a house and he never felt the need to do it
Shares of the company traded 8.15% down at Rs 1,330 at around 11.57 am (IST). On the other hand, the benchmark BSE Sensex was down 0.23% at 52,804.
Docon Technologies Pvt Ltd, a 100% subsidiary of API, will be the acquirer and shall make an open offer for an additional 26% stake
As part of the deal, Medlife will cease operations and its users will be able to use their log in credentials to access the PharmEasy app